The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Summary

Protocol is intended to characterize the overall safety and tolerability of eculizumab in this population.

Timeline

Start

2012-05-16

Primary completion

2013-09-24

Completion

2013-09-25

Publications

• Pugh D, O'Sullivan ED, Duthie FA, Masson P, Kavanagh D. Interventions for atypical haemolytic uraemic syndrome. Cochrane Database Syst Rev. 2021 Mar 23;3(3):CD012862. doi: 10.1002/14651858.CD012862.pub2.

Drugs

Indications